First-line treatment and overall survival in EGFR mutation-positive advanced non-small cell lung cancer: a national cohort study.
Saved in:
| Title: | First-line treatment and overall survival in EGFR mutation-positive advanced non-small cell lung cancer: a national cohort study. |
|---|---|
| Authors: | Huang LY; Division of Health Technology Assessment, Center for Drug Evaluation, Taipei, Taiwan. lyhuang277@cde.org.tw., Chang HP, Chang RY, Tai HY, Huang YW, Lee PC |
| Source: | European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2022 Oct; Vol. 26 (20), pp. 7632-7640. |
| Publication Type: | Observational Study; Journal Article |
| Journal Info: | Publisher: Verduci Country of Publication: Italy NLM ID: 9717360 Publication Model: Print Cited Medium: Internet ISSN: 2284-0729 (Electronic) Linking ISSN: 11283602 NLM ISO Abbreviation: Eur Rev Med Pharmacol Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
